The mechanisms of surface chemistry effects of mesoporous silicon nanoparticles on immunotoxicity and biocompatibility

Biomaterials

Volumn 34, Issue 31, 2013, Pages 7776-7789

  Shahbazi, Mohammad Ali ^a   Hamidi, Mehrdad ^b   Mäkilä, Ermei M ^a,c   Zhang, Hongbo ^a   Almeida, Patrick V ^a   Kaasalainen, Martti ^c   Salonen, Jarno J ^c   Hirvonen, Jouni T ^a   Santos, Hélder A ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b ZANJAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c UNIVERSITY OF TURKU   (Finland)

Author keywords

Erythrocytes; Genotoxicity; Hemocompatibility; Histopathology; Immune cells; Porous silicon nanoparticles

Indexed keywords

ERYTHROCYTES; GENOTOXICITIES; HEMOCOMPATIBILITY; HISTOPATHOLOGY; IMMUNE CELLS; SILICON NANOPARTICLES;

BIOCOMPATIBILITY; BLOOD; CELL MEMBRANES; HYDROPHILICITY; NANOPARTICLES; POROUS SILICON; SURFACE CHEMISTRY;

CYTOLOGY;

ASPARTATE AMINOTRANSFERASE; LACTATE DEHYDROGENASE; NANOPARTICLE; SILICON; SODIUM; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BIOCOMPATIBILITY; CELL MEMBRANE; CELL STRUCTURE; CONCENTRATION (PARAMETERS); CONCENTRATION RESPONSE; CONTROLLED STUDY; DEFENSE MECHANISM; DNA DAMAGE; DNA STRAND; ENDOPLASMIC RETICULUM; GENOTOXICITY; HALF LIFE TIME; HEMOLYSIS; HYDROGEN BOND; HYDROPHILICITY; HYDROPHOBICITY; IMMUNOGLOBULIN PRODUCING CELL; IMMUNOTOXICITY; IN VITRO STUDY; IN VIVO STUDY; LEUKEMIA CELL LINE; LIPID BILAYER; MALE; MEMBRANE STRUCTURE; MITOCHONDRIAL MEMBRANE POTENTIAL; NONHUMAN; OXIDATIVE STRESS; PARTICLE SIZE; PHASE TRANSITION; PRIORITY JOURNAL; RAT; RESPIRATORY CHAIN; SURFACE CHARGE;

EID: 84880953680     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2013.06.052     Document Type: Article

References (53)

1. Santos H.A., Bimbo L.M., Lehto V.P., Airaksinen A.J., Salonen J., Hirvonen J. Multifunctional porous silicon for therapeutic drug delivery and imaging. Curr Drug Discov Technol 2011, 8:228-249.
2. Sarparanta M., Bimbo L.M., Rytkönen J., Mäkilä E., Laaksonen T.J., Laaksonen P., et al. Intravenous delivery of hydrophobin-functionalized porous silicon nanoparticles: stability, plasma protein adsorption and biodistribution. Mol Pharm 2012, 9:654-663.
3. Shahbazi MA, Hamidi M. The impact of preparation parameters on typical attributes of chitosan-heparin nanohydrogels: particle size, loading efficiency, and drug release. Drug Dev Ind Pharm. doi:10.3109/03639045.2012.736518.
4. Hamidi M., Shahbazi M.A., Rostamizadeh K. Copolymers: efficient carriers for intelligent nanoparticulate drug targeting and gene therapy. Macromol Biosci 2012, 12:144-164.
5. Elsaesser A., Howard C.V. Toxicology of nanoparticles. Adv Drug Deliv Rev 2012, 64:129-137.
6. Yu T., Greish K., McGill L.D., Ray A., Ghandehari H. Influence of geometry, porosity, and surface characteristics of silica nanoparticles on acute toxicity: their vasculature effect and tolerance threshold. ACS Nano 2012, 6:2289-2301.
7. Nel A., Xia T., Madler L., Li N. Toxic potential of materials at the nanolevel. Science 2006, 311:622-627.
8. Sharifi S., Behzadi S., Laurent S., Forrest M.L., Stroeve P., Mahmoudi M. Toxicity of nanomaterials. Chem Soc Rev 2012, 41:2323-2343.
9. Santos H.A., Bimbo L.M., Herranz B., Shahbazi M.A., Hirvonen J., Salonen J. Nanostructured porous silicon in preclinical imaging: moving from bench to bed side. JMater Res 2013, 28:152-164.
10. Bimbo L.M., Mäkilä E., Laaksonen T., Lehto V.P., Salonen J., Hirvonen J., et al. Drug permeation across intestinal epithelial cells using porous silicon nanoparticles. Biomaterials 2011, 32:2625-2633.
11. Schins R.P. Mechanisms of genotoxicity of particles and fibers. Inhal Toxicol 2002, 14:57-78.
12. Choi H.-S., Kim Y.-J., Song M., Song M.-K., Ryu J.-C. Genotoxicity of nano-silica in mammalian cell lines. Toxicol Environ Heal Sci 2011, 3:7-13.
13. Singh N., Manshian B., Jenkins G.J., Griffiths S.M., Williams P.M., Maffeis T.G., et al. NanoGenotoxicology: the DNA damaging potential of engineered nanomaterials. Biomaterials 2009, 30:3891-3914.
14. Bimbo L.M., Sarparanta M., Santos H.A., Airaksinen A.J., Mäkilä E., Laaksonen T., et al. Biocompatibility of thermally hydrocarbonized porous silicon nanoparticles and their biodistribution in rats. ACS Nano 2010, 4:3023-3032.
15. Bimbo L.M., Sarparanta M., Mäkilä E., Laaksonen T., Laaksonen P., Salonen J., et al. Cellular interactions of surface modified nanoporous silicon particles. Nanoscale 2012, 4:3184-3192.
16. Liu D., Mäkilä E., Zhang H., Herranz B., Kaasalainen M., Kinnari P., et al. Nanostructured porous silicon-solid lipid nanocomposite: towards enhanced cytocompatibility and stability, reduced cellular association and prolonged drug release. Adv Funct Mater 2013, 23:1893-1902.
17. Santos H.A., Riikonen J., Salonen J., Mäkilä E., Heikkilä T., Laaksonen T., et al. Invitro cytotoxicity of porous silicon microparticles: effect of the particle concentration, surface chemistry and size. Acta Biomater 2010, 6:2721-2731.
18. Kim S.T., Saha K., Kim C., Rotello V.M. The role of surface functionality in determining nanoparticle cytotoxicity. Acc Chem Res 2013, 46:681-691.
19. Asefa T., Tao Z. Biocompatibility of mesoporous silica nanoparticles. Chem Res Toxicol 2012, 25:2265-2284.
20. Jaganathan H., Godin B. Biocompatibility assessment of Si-based nano- and micro-particles. Adv Drug Deliv Rev 2012, 64:1800-1819.
21. Meng H., Xia T., George S., Nel A.E. Apredictive toxicological paradigm for the safety assessment of nanomaterials. ACS Nano 2009, 3:1620-1627.
22. Oh W.K., Kim S., Choi M., Kim C., Jeong Y.S., Cho B.R., et al. Cellular uptake, cytotoxicity, and innate immune response of silica-titania hollow nanoparticles based on size and surface functionality. ACS Nano 2010, 4:5301-5313.
23. Lai D.Y. Toward toxicity testing of nanomaterials in the 21st century: a paradigm for moving forward. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2012, 4:1-15.
24. Ruizendaal L., Bhattacharjee S., Pournazari K., Rosso-Vasic M., Haan LHJd, Alink G.M., et al. Synthesis and cytotoxicity of silicon nanoparticles with covalently attached organic monolayers. Nanotoxicology 2009, 3:339-347.
25. Peakman M., Vergani D. Basic and clinical immunology 2009, Elsevier Health Sciences.
26. Zhao Y., Sun X., Zhang G., Trewyn B.G., Slowing, Lin V.S. Interaction of mesoporous silica nanoparticles with human red blood cell membranes: size and surface effects. ACS Nano 2011, 5:1366-1375.
27. Yu T., Malugin A., Ghandehari H. Impact of silica nanoparticle design on cellular toxicity and hemolytic activity. ACS Nano 2011, 5:5717-5728.
28. Joglekar M., Roggers R.A., Zhao Y., Trewyn B.G. Interaction effects of mesoporous silica nanoparticles with different morphologies on human red blood cells. RSC Adv 2013, 3:2454-2461.
29. Shanta Singh N., Kulkarni H., Pradhan L., Bahadur D. Amultifunctional biphasic suspension of mesoporous silica encapsulated with YVO4:Eu3+ and Fe3O4 nanoparticles: synergistic effect towards cancer therapy and imaging. Nanotechnology 2013, 24:065101.
30. Fisichella M., Berenguer F., Steinmetz G., Auffan M., Rose J., Prat O. Intestinal toxicity evaluation of TiO2 degraded surface-treated nanoparticles: a combined physico-chemical and toxicogenomics approach in caco-2 cells. Part Fibre Toxicol 2012, 9:18.
31. Dini L., Abbro L. Bioeffects of moderate-intensity static magnetic fields on cell cultures. Micron 2005, 36:195-217.
32. Tao Z., Toms B.B., Goodisman J., Asefa T. Mesoporosity and functional group dependent endocytosis and cytotoxicity of silica nanomaterials. Chem Res Toxicol 2009, 22:1869-1880.
33. Xia T., Kovochich M., Liong M., Zink J.I., Nel A.E. Cationic polystyrene nanosphere toxicity depends on cell-specific endocytic and mitochondrial injury pathways. ACS Nano 2008, 2:85-96.
34. Xia T., Kovochich M., Liong M., Madler L., Gilbert B., Shi H., et al. Comparison of the mechanism of toxicity of zinc oxide and cerium oxide nanoparticles based on dissolution and oxidative stress properties. ACS Nano 2008, 2:2121-2134.
35. Batandier C., Fontaine E., Keriel C., Leverve X.M. Determination of mitochondrial reactive oxygen species: methodological aspects. JCell Mol Med 2002, 6:175-187.
36. Sayes C.M., Reed K.L., Warheit D.B. Assessing toxicity of fine and nanoparticles: comparing invitro measurements to invivo pulmonary toxicity profiles. Toxicol Sci 2007, 97:163-180.
37. Bhattacharjee S., de Haan L.H., Evers N.M., Jiang X., Marcelis A.T., Zuilhof H., et al. Role of surface charge and oxidative stress in cytotoxicity of organic monolayer-coated silicon nanoparticles towards macrophage NR8383 cells. Part Fibre Toxicol 2010, 7:25.
38. Brorson J.R., Schumacker P.T., Zhang H. Nitric oxide acutely inhibits neuronal energy production. The Committees on Neurobiology and Cell Physiology. JNeurosci 1999, 19:147-158.
39. Zhu M.T., Wang Y., Feng W.Y., Wang B., Wang M., Ouyang H., et al. Oxidative stress and apoptosis induced by iron oxide nanoparticles in cultured human umbilical endothelial cells. JNanosci Nanotechnol 2010, 10:8584-8590.
40. Brown G.C., Borutaite V. Nitric oxide inhibition of mitochondrial respiration and its role in cell death. Free Radic Biol Med 2002, 33:1440-1450.
41. Park E.J., Park K. Oxidative stress and pro-inflammatory responses induced by silica nanoparticles invivo and invitro. Toxicol Lett 2009, 184:18-25.
42. Erusalimsky J.D., Moncada S. Nitric oxide and mitochondrial signaling: from physiology to pathophysiology. Arterioscler Thromb Vasc Biol 2007, 27:2524-2531.
43. Langer D.A., Das A., Semela D., Kang-Decker N., Hendrickson H., Bronk S.F., et al. Nitric oxide promotes caspase-independent hepatic stellate cell apoptosis through the generation of reactive oxygen species. Hepatology 2008, 47:1983-1993.
44. Perez-Rodriguez R., Fuentes M.P., Olivan A.M., Martinez-Palacian A., Roncero C., Gonzalez M.P., et al. Mechanisms of nitric oxide-induced apoptosis in bovine chromaffin cells: role of mitochondria and apoptotic proteins. JNeurosci Res 2007, 85:2224-2238.
45. Bhattacharjee S., Ershov D., Fytianos K., van der Gucht J., Alink G.M., Rietjens I.M., et al. Cytotoxicity and cellular uptake of tri-block copolymer nanoparticles with different size and surface characteristics. Part Fibre Toxicol 2012, 9:11.
46. Chang J.S., Chang K.L., Hwang D.F., Kong Z.L. Invitro cytotoxicity of silica nanoparticles at high concentrations strongly depends on the metabolic activity type of the cell line. Environ Sci Technol 2007, 41:2064-2068.
47. Chowdhury R., Chatterjee R., Giri A.K., Mandal C., Chaudhuri K. Arsenic-induced cell proliferation is associated with enhanced ROS generation, Erk signaling and CyclinA expression. Toxicol Lett 2010, 198:263-271.
48. Fabrikant J.I. Adaptation of cell renewal systems under continuous irradiation. Health Phys 1987, 52:561-570.
49. Ward J.F. DNA damage as the cause of ionizing radiation-induced gene activation. Radiat Res 1994, 138:S85-S88.
50. AshaRani P.V., Low Kah Mun G., Hande M.P., Valiyaveettil S. Cytotoxicity and genotoxicity of silver nanoparticles in human cells. ACS Nano 2009, 3:279-290.
51. Xia T., Kovochich M., Brant J., Hotze M., Sempf J., Oberley T., et al. Comparison of the abilities of ambient and manufactured nanoparticles to induce cellular toxicity according to an oxidative stress paradigm. Nano Lett 2006, 6:1794-1807.
52. Besic Gyenge E., Darphin X., Wirth A., Pieles U., Walt H., Bredell M., et al. Uptake and fate of surface modified silica nanoparticles in head and neck squamous cell carcinoma. JNanobiotechnol 2011, 9:32.
53. Junqueira U.C., Carneiro J. Basic histology: text & atlas 2005, McGraw-Hill Professional.